You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

Details for Patent: 9,278,123

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 9,278,123 protect, and when does it expire?

Patent 9,278,123 protects RYBELSUS and is included in one NDA.

This patent has thirty-six patent family members in twenty countries.

Summary for Patent: 9,278,123

Title:	Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
Abstract:	The present invention relates to solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and their use in medicine.
Inventor(s):	Sauerberg; Per (Farum, DK), Bjerregaard; Simon (Hilleroed, DK), Nielsen; Flemming Seier (Roskilde, DK)
Assignee:	Novo Nordisk A/S (Bagsvaerd, DK)
Application Number:	13/994,262
Patent Claim Types: see list of patent claims	Use; Composition; Compound; Dosage form;

Drugs Protected by US Patent 9,278,123

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Novo	RYBELSUS	semaglutide	TABLET;ORAL	213051-001	Sep 20, 2019		RX	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			METHOD OF TREATING TYPE 2 DIABETES MELLITUS	⤷ Sign Up
Novo	RYBELSUS	semaglutide	TABLET;ORAL	213051-002	Sep 20, 2019		RX	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			METHOD OF TREATING TYPE 2 DIABETES MELLITUS	⤷ Sign Up
Novo	RYBELSUS	semaglutide	TABLET;ORAL	213051-003	Sep 20, 2019		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			METHOD OF TREATING TYPE 2 DIABETES MELLITUS	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 9,278,123

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	10195285	Dec 16, 2010

PCT Information
PCT Filed	December 16, 2011	PCT Application Number:	PCT/EP2011/073060
PCT Publication Date:	June 21, 2012	PCT Publication Number:	WO2012/080471

International Family Members for US Patent 9,278,123

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2011343190	⤷ Sign Up
Brazil	112013014942	⤷ Sign Up
Canada	2821886	⤷ Sign Up
China	103260608	⤷ Sign Up
China	105963685	⤷ Sign Up
Cyprus	1121118	⤷ Sign Up
Denmark	2651398	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.